Siebert, S., Coates, L., Schett, G., Raychaudhuri, S., Chen, W., Gao, S., . . . Deodhar, A. (2024). Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis. Wiley.
Citación estilo ChicagoSiebert, S., et al. Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis. Wiley, 2024.
Cita MLASiebert, S., et al. Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis. Wiley, 2024.
Warning: These citations may not always be 100% accurate.